jimei（kinase）shichaojiazuyaowubabiao，baohanduogechengyuan，shizhiyaogongyehexueshuyanjiudezhuyaoyanjiulingyu。jimeixinhaochuandaotujingzaidiaojiexibaozengzhi、daixiehesiwangzhongqizhezuoyong，yincijimeihuoxingdebianhuakenenghuidaozhibaokuoaizhengzaineidegezhongjibingxingtai。yiner，jimeideshangshuzhongyaotezhengshiqichengweiyaowushaixuanhefaxianzhongdemubiaojiazuzhiyi。zaiguoqujinianzhong，keyanrenyuanbuduandizengjiajimeizuoweizhongyaoyaowudeshibiebabiao。jiezhimuqian，fdayijingpizhunleduozhongjimeiyizhiji。
为了支持激酶类药物的筛选、发现与开发，安必奇生物为您提供多种激酶类型，从检测方法开发、筛选到选择性分析等一系列激酶研究解决方案。应用biochemical-based assays和cell-based assaysjinxingyaowuhouxuanhuahewudegezhonggongnengxingpinggu，weinintigongshiyanjishufangan。
基于生化检测的激酶筛选biochemical-based assays
shenghuajiancefenxi：baokuofangshexingjiehedejimeihuoxingfenxi；tr-fretjiancediwulinsuanhuashuiping；caliperfenxi；luminescencefenxi；lc-msjiance；imapfenxi；yijiadp-questjiancedeng。
基于细胞的激酶筛选cell-based assays
xibaojiancefenxi：baokuojimeihuoxingpingjia；huahewujieheshiyan；danbaihuzuojiance；xibaoxuanzexingshaixuanfenxideng。
服务优势
kuaisu&gaoxiao；
guangfandejimeibadianleixing，chaoguo200zhongbutongjimeideshaixuanhefenxi；
shiyanlinghuo，dandianjiehejiancefenxi&ic50jiancefenxi；
duozhongjiancefangfa，manzuninzaiyaowushaixuanfangmiandexuqiu；
yangebaozhengxinxianquan，qiandingbaomihetongzhixingfuwu。
样品提供
zhixuyaotigongdaicebadiandehuahewu，womenhuiweininanpaixiangyingdeshaixuanhejiancefuwu，ranhoutigongjininzhuanyedejiandingbaogao。
感谢您选择安必奇生物的激酶筛选与分析服务。如有任何相关的问题，请发送邮件至info@jsbilifu.com，或拨打电话15001325569，anbiqishengwudejishuzhichijiangjiechengweininfuwu。
参考文献：
bello, t., & gujral, t. s. (2018). kinhibition: a kinase inhibitor selection portal. iscience, 8, 49–53. doi:10.1016/j.isci.2018.09.009.
de, g. c. o. , hsia, j. e. , anzola, j. v. , amir, m. , michelle, y. , & liang, w. y. , et al. (2015). a cell biologist's field guide to aurora kinase inhibitors. frontiers in oncology, 5.
normandin, k. , lavallée, jean-fran?ois, futter, m. , beautrait, a. , duchaine, j. , & guiral, sébastien, et al. (2016). identification of polo-like kinase 1 interaction inhibitors using a novel cell-based assay. scientific reports, 5, 37581.
